Perbedaan Perdana Gapuraprima Tbk. dan Organon Pharma Indonesia Tbk.: Perdana Gapuraprima Tbk. diperdagangkan di Rp105 (kapitalisasi pasar 444,77 M, volume 24 jam 128,05 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Perdana Gapuraprima Tbk. jauh lebih besar — sekitar 4,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GPRA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 444,77 M | 104,4 M |
Volume | 128,05 jt | — |
Lot | 1,28 jt | — |
Perputaran | 13,21 M | — |
Harga Rata-rata | 103,18 | — |
Nilai Transaksi | 13,21 M | — |
Harga Ekuilibrium Indikatif | 105 | — |
Volume Ekuilibrium Indikatif | 4,51 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Perdana Gapuraprima Tbk was established at Jakarta under the name of PT Perdana Gapura Mas on May 21, 1987. The Company’s articles of association has been amended several times, most recently by notarial deed No. 109 of Mrs. Leolin J, S.H., dated Jun 29, 2007, concerning among others, the change in the Company’s name, paid up capital and public offering of stock.
Selengkapnya di halaman GPRA →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →